BACKGROUND: The association between hospitalization for respiratory syncytial virus (RSV) infection in infancy and asthma/wheezing in later life has long been studied. However, no published studies have combined systematic review and meta-analysis of existing evidence. PURPOSE: To quantify the link between RSV hospitalization in early life and subsequent diagnosis of asthma. METHOD: A systematic search was conducted using MEDLINE and EMBASE databases. Studies were selected for meta-analysis if they assessed the association between RSV-confirmed hospitalization for up to 3 years of age and asthma/wheezing later in life. Potential sources of heterogeneity were identified by stratified analysis. RESULTS: Twenty articles representing 15 unique studies of 82,008 unique individuals (including 1533 with RSV-confirmed hospitalization) were selected for meta-analysis. Children who had RSV disease in early life had a higher incidence of asthma/wheezing in later life (odds ratio: 3.84; 95% confidence interval: 3.23-4.58). There was moderate heterogeneity between studies (I² = 45%). The association was found to decrease with age at follow-up, consistent with the findings of longitudinal studies. When age at follow-up was considered, heterogeneity was low (residual I² = 17%). LIMITATIONS: Study quality was generally poor because randomization to hospitalization for RSV infection was not possible, appropriate blinding was rare and adjustment for confounding variables was not always appropriate. CONCLUSIONS: The meta-analysis suggests an association between infant RSV hospitalization and respiratory morbidity that decreases with age. If the association is causal, the development of an effective vaccine against RSV could decrease the burden of asthma.
BACKGROUND: The association between hospitalization for respiratory syncytial virus (RSV) infection in infancy and asthma/wheezing in later life has long been studied. However, no published studies have combined systematic review and meta-analysis of existing evidence. PURPOSE: To quantify the link between RSV hospitalization in early life and subsequent diagnosis of asthma. METHOD: A systematic search was conducted using MEDLINE and EMBASE databases. Studies were selected for meta-analysis if they assessed the association between RSV-confirmed hospitalization for up to 3 years of age and asthma/wheezing later in life. Potential sources of heterogeneity were identified by stratified analysis. RESULTS: Twenty articles representing 15 unique studies of 82,008 unique individuals (including 1533 with RSV-confirmed hospitalization) were selected for meta-analysis. Children who had RSV disease in early life had a higher incidence of asthma/wheezing in later life (odds ratio: 3.84; 95% confidence interval: 3.23-4.58). There was moderate heterogeneity between studies (I² = 45%). The association was found to decrease with age at follow-up, consistent with the findings of longitudinal studies. When age at follow-up was considered, heterogeneity was low (residual I² = 17%). LIMITATIONS: Study quality was generally poor because randomization to hospitalization for RSV infection was not possible, appropriate blinding was rare and adjustment for confounding variables was not always appropriate. CONCLUSIONS: The meta-analysis suggests an association between infantRSV hospitalization and respiratory morbidity that decreases with age. If the association is causal, the development of an effective vaccine against RSV could decrease the burden of asthma.
Authors: Nipasiri Voraphani; Debra A Stern; Anne L Wright; Stefano Guerra; Wayne J Morgan; Fernando D Martinez Journal: Am J Respir Crit Care Med Date: 2014-08-15 Impact factor: 21.405
Authors: Lindsay Kim; Brian Rha; Jon S Abramson; Larry J Anderson; Carrie L Byington; Grace L Chen; John DeVincenzo; Kathryn M Edwards; Janet A Englund; Ann R Falsey; Marie R Griffin; Ruth A Karron; Karen G Martin; H Cody Meissner; Flor M Munoz; Andrew T Pavia; Pedro A Piedra; William Schaffner; Eric A F Simões; Rosalyn Singleton; H Keipp Talbot; Edward E Walsh; Jane R Zucker; Susan I Gerber Journal: Clin Infect Dis Date: 2017-09-15 Impact factor: 9.079
Authors: Kei E Fujimura; Tine Demoor; Marcus Rauch; Ali A Faruqi; Sihyug Jang; Christine C Johnson; Homer A Boushey; Edward Zoratti; Dennis Ownby; Nicholas W Lukacs; Susan V Lynch Journal: Proc Natl Acad Sci U S A Date: 2013-12-16 Impact factor: 11.205
Authors: Christian Rosas-Salazar; Meghan H Shilts; Andrey Tovchigrechko; Seth Schobel; James D Chappell; Emma K Larkin; Tebeb Gebretsadik; Rebecca A Halpin; Karen E Nelson; Martin L Moore; Larry J Anderson; R Stokes Peebles; Suman R Das; Tina V Hartert Journal: J Allergy Clin Immunol Date: 2018-01-10 Impact factor: 10.793